- Coalition Forces of Immunologists and Oncologists for Defeating Cancer
-
Shin EC
- KMID: 2471041
- Immune Netw.
- 2020 Feb;20(1):e1.
- doi: 10.4110/in.2020.20.e1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
-
Kim JH, Kim BS, Lee SK
- KMID: 2471044
- Immune Netw.
- 2020 Feb;20(1):e4.
- doi: 10.4110/in.2020.20.e4
Tregs have a role in immunological tolerance and immune homeostasis by suppressing immune reactions, and its therapeutic potential is critical in autoimmune diseases and cancers. There have been multiple studies... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
-
Choi J, Lee SY
- KMID: 2471049
- Immune Netw.
- 2020 Feb;20(1):e9.
- doi: 10.4110/in.2020.20.e9
Immune checkpoint inhibitors (ICIs) have been changing the paradigm of cancer treatment. However, immune-related adverse effects (irAEs) have also increased with the exponential increase in the use of ICIs. ICIs... -
- CITED
-
- Close
- SHARE
-
- Close
- Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
-
Kim KH, Kim CG, Shin EC
- KMID: 2471048
- Immune Netw.
- 2020 Feb;20(1):e8.
- doi: 10.4110/in.2020.20.e8
Immune checkpoint blockade targeting PD-1 and PD-L1 has resulted in unprecedented clinical benefit for cancer patients. Anti-PD-1/PD-L1 therapy has become the standard treatment for diverse cancer types as monotherapy or... -
- CITED
-
- Close
- SHARE
-
- Close
- Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
-
Jeong S, Park SH
- KMID: 2471043
- Immune Netw.
- 2020 Feb;20(1):e3.
- doi: 10.4110/in.2020.20.e3
Immune checkpoint inhibitors (ICIs), including anti-PD-1 and anti-CTLA-4 therapeutic agents, are now approved by the Food and Drug Administration for treatment of various types of cancer. However, the therapeutic efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
-
Lee HW, Cho KJ, Park JY
- KMID: 2471051
- Immune Netw.
- 2020 Feb;20(1):e11.
- doi: 10.4110/in.2020.20.e11
Most patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage of disease. Until recently, systemic treatment options that showed survival benefits in HCC have been limited to tyrosine... -
- CITED
-
- Close
- SHARE
-
- Close
- IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
-
Kuen DS, Kim BS, Chung Y
- KMID: 2471046
- Immune Netw.
- 2020 Feb;20(1):e6.
- doi: 10.4110/in.2020.20.e6
IL-17 is produced by RAR-related orphan receptor gamma t (RORγt)-expressing cells including Th17 cells, subsets of γδT cells and innate lymphoid cells (ILCs). The biological significance of IL-17-producing cells is... -
- CITED
-
- Close
- SHARE
-
- Close
- Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis
-
Oh SJ, Lee J, Kim Y, Song KH, Cho E, Kim M, Jung H, Kim TW
- KMID: 2471047
- Immune Netw.
- 2020 Feb;20(1):e7.
- doi: 10.4110/in.2020.20.e7
Cancer immunotherapy, in the form of vaccination, adoptive cellular transfer, or immune checkpoint inhibitors, has emerged as a promising practice within the field of oncology. However, despite the developing field's... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
-
Lim SM, Hong MH, Kim HR
- KMID: 2471050
- Immune Netw.
- 2020 Feb;20(1):e10.
- doi: 10.4110/in.2020.20.e10
Immune checkpoint inhibitors (ICIs) have shown remarkable benefit in the treatment of patients with non-small-cell lung cancer (NSCLC) and have emerged as an effective treatment option even in the first-line... -
- CITED
-
- Close
- SHARE
-
- Close
- Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
-
Im SJ, Ha SJ
- KMID: 2471042
- Immune Netw.
- 2020 Feb;20(1):e2.
- doi: 10.4110/in.2020.20.e2
Acute viral infection or vaccination generates highly functional memory CD8 T cells following the Ag resolution. In contrast, persistent antigenic stimulation in chronic viral infection and cancer leads to a... -
- CITED
-
- Close
- SHARE
-
- Close
- Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity
-
Lee HW, Chung YS, Kim TJ
- KMID: 2471045
- Immune Netw.
- 2020 Feb;20(1):e5.
- doi: 10.4110/in.2020.20.e5
The γδ T cells are unconventional lymphocytes that function in both innate and adaptive immune responses against various intracellular and infectious stresses. The γδ T cells can be exploited as... -
- CITED
-
- Close
- SHARE
-
- Close
